Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Upkara

start up
United States - Ann Arbor , Michigan
  • 18/05/2023
  • Series A
  • $9,000,000

Upkara is developing novel biopreservation technologies for the stabilization of a variety of biopharmaceuticals including proteins, nucleic acids, viruses and cells. The technology is broadly applicable and we are currently evaluating opportunities within the analytical testing, diagnostic testing and human medicine markets with the aim of global commercialization and elimination of cold-chain requirements. Ultimately, Upkara desires that our technology has a strong social impact by enabling the delivery of life-saving medicines to regions lacking the critical infrastructure required for medical storage.


Related People

Alan TurfeFounder

Alan Turfe United States - Ann Arbor, Michigan

Alan serves as CEO and Chairman of the Board at Upkara Corporation, a biotech company, with operations in Ann Arbor and Novi, Michigan and Melbourn, Australia. Upkara eliminates the "cold chain" pharmaceutical supply chain requirements of therapeutics, vaccines and reagents with our innovative, patented, biopreservation technology. Under Alan's leadership, our product innovations will enable incremental revenues in animal and human health markets.

Previously, Alan served as CEO of J M Smith Corporation, a $3.0 billion business with full P&L responsibility for nine business units. J M Smith Corporation wholesales and distributes pharmaceutical products and is also a leader in providing technology solutions to its chain, retail pharmacy, and long-term care customers. Alan restructured the company from nine business units to just two: Smith Technologies and Smith Drug Company which resulted in Smith Technologies being sold to Francisco Partners in April/2020.

Alan is an accomplished leader focused on commercial growth, innovation, and operational excellence in distribution, manufacturing, service, and technology. He has served in officer positions within healthcare, pharma, medical device, biotechnology, industrial, and internet e-commerce. Functionally, Alan has also been a CFO, Chief Commercial Officer, Chief Procurement Officer, Group VP of Operations, and VP of Merchandising. A proven track record of increasing customer enthusiasm and shareholder value through developing strategic plans, building high performing organizations, and enhancing operational efficiency in both turn around and high growth situations.